BackClarity Pharmaceuticals Overview

Clarity Pharmaceuticals Other Current Liabilities

Latest other current liabilities for CU6.AX: $2.5M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$2.52M
↓ 78.17% YoYΔ $-9.01M vs prior year quarter

Peer trimmed avg / median

Loading

Clarity Pharmaceuticals Other Current Liabilities History

Loading

Clarity Pharmaceuticals vs. peers: Other Current Liabilities Comparison

Loading

Clarity Pharmaceuticals Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Clarity Pharmaceuticals (CU6.AX) FAQ

As of the most recent data (June 2026), CU6.AX shows a other current liabilities of $2.5M. That compares with $12M in the prior-year period — down 78.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CU6.AX's other current liabilities is now $2.5M (was $12M) — a 78.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Clarity Pharmaceuticals is outperforming or lagging.

Tracking CU6.AX's other current liabilities over time shows whether Clarity Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $12M in the prior-year period — down 78.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Clarity Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $2.5M) with ownership activity and broader fundamentals.